Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

3 recruiting

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT06555848Recruiting

CERAMENT G as Part of the Surgical Treatment of Osteomyelitis in a Single-Stage Procedure

Role: lead

NCT04244942Recruiting

CERAMENT™| Bone Void Filler Device Registry

Role: lead

NCT06010433Recruiting

CERAMENT G Device Registry

Role: lead

NCT06628115Not ApplicableNot Yet Recruiting

Post Market Study of Cerament V/G in Pedal Osteomyelitis

Role: collaborator

NCT02820363Not ApplicableCompleted

Study Evaluating CERAMENT™|G in Open Diaphyseal Tibial Fractures

Role: lead

All 5 trials loaded